Loading provider…
Loading provider…
Infectious Disease Physician in Fort Pierce, FL
NPI: 1457329450Primary Practice Location
Midway Specialty Care Center Inc
356 E Midway Rd, Fort Pierce, FL
Primary Employer
Midway Specialty Care Center Inc
midwaycare.org
HQ Phone
Get MD Moti's Phone Numberphone_androidMobile
Get MD Moti's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1996 - 2026
MI State Medical License
1994 - 1998

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Infectious Disease
University of Miami/Jackson Health System
Fellowship • Infectious Disease
1995 - 1997
Bon Secours Hospital
Residency • Internal Medicine
1992 - 1995
University of the West Indies Faculty of Medical Sciences
Medical School
Until 1989
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 238 | 428 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 209 | 413 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 155 | 230 |
| 4 | 36415Insertion of needle into vein for collection of blood sample | 154 | 309 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 135 | 182 |
Authors: Mezgebe Berhe, Indira Brar, Cynthia Brinson, Peter Ruane
Journal: Medicine (Baltimore)
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation
Authors: Karam Mounzer, Robert Bolan, Jason Okulicz, Michelle Salvaggio, Larry Bush, Paul Skolnik, Claudia Goulston, Randy Taplitz, Susan Olender, Otto Yang, Jacqueline O'Leary, Richard Haubrich, Eunice Pae, Harry Lampiris, George Cuchural, Anita Fleenor-Ford, Michael Lederman, Clifford Kinder, Kenneth Davis, Lawrence Price
Lead Sponsor: TaiMed Biologics Inc.
Intervention / Treatment: BIOLOGICAL: ibalizumab, DRUG: Optimized Background Regimen (OBR)
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Budigalimab, DRUG: ABBV-382, DRUG: Placebo for ABBV-382, DRUG: Placebo for Budigalimab
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Placebo, DRUG: ABBV-181
Journal: Science
Publication Date: 2010-11-04